Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | MMP1 | P03956 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.38 |
| ▸ | MMP8 | P22894 | 2/20 | 0.38 |
| ▸ | MMP13 | P45452 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Perflenapent SCHEMBL7648533 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL984715 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL3743142 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL1924377 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| Perflexane SCHEMBL3671912 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL1707474 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| Perflexane SCHEMBL7507426 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL1779065 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL771546 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| Perflexane SCHEMBL20769778 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10608 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144875-A1 | COMPOSITIONS AND METHODS FOR CROSSLINKING STRUCTURAL PROTEINS | ADS THERAPEUTICS LLC (US) | 2026-05-28 | — | — | US | claimed |
| CN-122079731-A | Preparation method of cis-1, 2-dibromoethylene based on steric hindrance effect | — | 2026-05-26 | — | — | CN | claimed |
| CN-122091709-A | Composite solid electrolyte, preparation method thereof and secondary battery containing composite solid electrolyte | — | 2026-05-26 | — | — | CN | claimed |
| CN-122075972-A | Gas-liquid dual-core fire-extinguishing microcapsule and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122075746-A | Microsphere composition, preparation method thereof and application thereof in preparation of contrast agent and medicine | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026106498-A1 | PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES | NanoSanguis S.A. (PL) | 2026-05-21 | — | — | WO | claimed |
| EP-4744487-A1 | FLUID, METHODS OF PRODUCING FLUID, AND ITS USES | NanoSanguis S.A. (PL) | 2026-05-20 | — | — | EP | claimed |
| EP-4744486-A1 | PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES. | NanoSanguis S.A. (PL) | 2026-05-20 | — | — | EP | claimed |
| US-12622812-B2 | Otological surgery under perfluorocarbon liquids | ALCON INC. (CH) | 2026-05-12 | — | — | US | claimed |
| EP-3759213-B1 | METHODS, COMPOSITIONS, AND DEVICES FOR ISOLATION AND EXPRESSION ANALYSIS OF REGIONS OF INTEREST FROM A TISSUE | QUANTUMCYTE INC (US) | 2026-04-29 | — | — | EP | claimed |
| EP-0307074-A2 | Antifouling coating for polymerisation reactors | Crown Berger Limited (GB) | 1989-03-15 | — | — | EP | claimed |
| US-4803013-A | IMPROVED DIELECTRIC PROPERTIES, HYDROGEN ABSORPTION, FLUIDITY, VISCOSITY STABILITY | NIPPON OIL CO., LTD. (JP) | 1989-02-07 | — | — | US | claimed |
| EP-0296661-A2 | Single-phase composition containing a perfluorinated oil and one or more surfactant(s), useful as an excipient for cosmetic and dermatologic formulations, as well as for biomedical applications | ENIRICERCHE S.p.A. (IT) | 1988-12-28 | — | — | EP | claimed |
| US-4793931-A | EXTRACTION WITH PERFLUORINATED SOLVENT, ULTRAVIOLET RADIATION, AND PHOTODEGRADATION | SOLARCHEM RESEARCH, A DIVISION OF BROLOR INVESTMENTS LIMITED (CA) | 1988-12-27 | — | — | US | claimed |
| EP-0284297-A1 | Halogenated Naphthalene Derivatives | NIPPON OIL CO. LTD. (JP) | 1988-09-28 | — | — | EP | claimed |
| US-4575387-A | Process for separating a multi-component gaseous mixture | INSTITUT FRANCAIS DU PETROLE (FR) | 1986-03-11 | — | — | US | claimed |
| EP-0052285-B1 | PROCESS FOR THE PREPARATION IN THE PURE STATE OF SATURATED PERFLUORALKYL-1-CARBOXYLIC ACIDS FROM PERFLUORALKYL-1-IODIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-09-28 | — | — | EP | claimed |
| US-4038276-A | PROCESS FOR THE PRODUCTION OF FINELY DIVIDED SOLID CYANURIC CHLORIDE | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-07-26 | — | — | US | claimed |
| US-3996226-A | METHOLATED MELAMINES | NOBEL HOECHST CHIMIE (FR) | 1976-12-07 | — | — | US | claimed |
| US-3989843-A | Emulsification of fluorocarbon compounds for biological application as oxygen transporters | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1976-11-02 | — | — | US | claimed |